IBM Stock Price Prediction: Revenue momentum meets a mixed short-term tape
What moved IBM stock
IBM shares are holding near $247.35 after a modest 24-hour advance, but the tape is not clean. The stock sits above its 7-day moving average at $246.31 and slightly above the 12-day EMA at $247.90, yet it remains below the 20-day SMA at $250.82. That combination points to a recovery attempt inside a broader short-term distribution pattern rather than a confirmed breakout.
IBM’s own third-quarter release on October 21, 2026, matters because management said revenue growth accelerated, led by Software and Infrastructure, and that full-year free cash flow guidance was raised. That is the fundamental backdrop traders are trying to price against. citeturn0search0
Technical setup: neutral momentum, overhead resistance still intact
Momentum is mixed, not stretched. IBM’s 14-day RSI is 52.19, which is neutral, while MACD sits aligned with its signal line at 1.7184, producing a flat histogram reading. Stochastic values at 33.07 and 26.46 suggest IBM is not overbought, but also not in a strong impulse phase.
The key levels are clear. Immediate resistance is $250.34, then stronger resistance at $253.34. On the downside, immediate support sits at $243.84, with stronger support at $240.34. The Bollinger middle band is $250.82 and the upper band is $259.81, so IBM has room to run if buyers can reclaim the 20-day average, but it still needs volume confirmation. Current volume versus the 5-day average is only 0.08x, which weakens the quality of the bounce.
Positioning on Binance perpetual futures
Derivatives positioning is firmer than the spot tape, but not decisive. Funding is flat at 0.0000%, so there is no obvious leverage premium on either side. Open interest is 16,705.86 contracts, with an 8.35% 24-hour increase, which shows fresh positioning is being built.
The cohort split is mixed. Binance global accounts are slightly net short at 49.2% long versus 50.8% short, while top traders are net long at 59.0% long versus 41.0% short. Taker flow leans bearish, with a buy/sell ratio of 0.7861, meaning aggressive selling has recently outweighed buying. Read together, that argues for caution: traders are engaged, but the flow is not yet confirming a clean upside breakout. citeturn0search1
Analyst targets: constructive, but not unanimous
The latest broker call in the evidence base came from Evercore ISI, which reiterated an Outperform rating and a $275 target on November 6, 2026. The firm’s sum-of-the-parts framing is notable because it implies IBM’s Software, Consulting, Infrastructure, IP/Other income, and Quantum businesses can be valued separately rather than as one blended multiple. On the broader analyst snapshot, 25 analysts polled by S&P Global show a consensus Buy rating and an average target of $259.85, with estimates ranging from $174 to $300. citeturn0search2turn0search3
That target spread matters. It suggests IBM has support from analysts, but the dispersion is wide enough to show disagreement on how much of the improved operating picture is already embedded in the share price. With IBM already near $247, the market is effectively asking whether the stock can clear the low-$250s and hold above the 20-day trend line.
Conditional view
If IBM can reclaim $250.34 and then $253.34 on better volume, the chart opens toward the upper Bollinger band at $259.81 and the analyst cluster in the high-$250s. If it fails to clear the 20-day average and loses $243.84, the next test is $240.34, where stronger support sits and where the recent rebound would start to look more like a countertrend move than a trend reversal.
The key question is not whether IBM has a fundamental story — it does, based on the third-quarter release — but whether price action can confirm that story before the stock stalls under resistance.